Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
With speculation online about OpenAI having reached the AGI stage of ChatGPT development, Sam Altman says that's not what's ...
ChatGPT became inaccessible for millions of users worldwide, showing a 'bad gateway error'. OpenAI promptly issued a fix.
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Some of the billionaire tech CEOs who now support Trump also seem to have adopted parts of his personality. Sooner or later, ...
Brazil stops Tools for Humanity from paying for iris scans over privacy worries. However, over 500,000 people sold their iris scans.